Patent · US Active

Pyruvate kinase activators for use in treating blood disorders

US11040036B2 · kind B2 · utility

6Cited by

2References

26Claims

0Family size

Assignee

Agios Pharmaceuticals, Inc. · US

Inventors

Giovanni Cianchetta · Waltham, US
Tao Liu · Shanghai, CN
Anil Kumar Padyana · Oxford, US
Zhihua Sui · Flemington, US
Zhenwei Cai · Skillman, US
Dawei Cui · Shanghai, CN
Jingjing Ji · Shanghai, CN

Key dates

Filing date	Nov 19, 2020
Grant date	Jun 22, 2021
Priority date	—
Expiry date	Nov 19, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are compounds that activate pyruvate kinase, pharmaceutical compositions and methods of use thereof. These compounds are represented by Formula (I) wherein R1, R2, Ra, Rb, Rj, Rk, and Q are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.